State of New Jersey Common Pension Fund D - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q2 2022$4,653,000
+124.5%
61,832
-19.9%
0.02%
+157.1%
Q1 2022$2,073,000
-38.0%
77,213
+10.2%
0.01%
-30.0%
Q4 2021$3,343,000
+20.3%
70,075
+67.5%
0.01%
+11.1%
Q3 2021$2,778,000
+1.2%
41,824
+18.9%
0.01%0.0%
Q2 2021$2,744,000
+9.8%
35,172
+33.1%
0.01%0.0%
Q1 2021$2,500,000
-10.7%
26,430
+15.0%
0.01%
-10.0%
Q4 2020$2,801,00022,9910.01%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q3 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 308,686$13,786,0008.42%
Cormorant Asset Management, LP 3,056,797$136,517,0006.34%
venBio Partners LLC 160,333$7,160,0006.10%
Burrage Capital Management LLC 77,172$3,250,0003.20%
Orbimed Advisors 2,745,327$122,606,0002.06%
Parkman Healthcare Partners LLC 80,318$3,587,0001.66%
SECTORAL ASSET MANAGEMENT INC 117,800$5,261,0001.01%
DAFNA Capital Management LLC 46,908$2,095,0000.87%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$1,542,0000.70%
Nicholas Investment Partners, LP 75,487$3,371,0000.66%
View complete list of TURNING POINT THERAPEUTICS I shareholders